Petauri Evidence Information

Petauri Evidence is an innovative business unit within the Petauri platform, dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making. At Petauri Evidence, we partner with Pharma and Medtech leaders to drive optimal global commercialisation. Programmes of support include: • Evidence, pricing and access strategy • Development of a robust evidence base • National, regional, and local reimbursement, and formulary inclusion • Communication of value to clinical and financial decision-makers Our clients benefit from collaborative, expert-driven, solutions-focused partnerships. We challenge and inspire them to achieve the best results, applying innovation and agility to everything we do. We have extensive experience in all therapy areas and deep expertise in rare disease, oncology, respiratory, diabetes and obesity, neurology, and immunology. Petauri Evidence was created when Mtech Access joined forces with Delta Hat in 2025, after both joining the Petauri platform in 2024. Why follow us on LinkedIn: With insights from our in-house market access and HEOR specialists, as well as an external network of healthcare professionals and other stakeholders, follow our LinkedIn page for: - Discussion of recent and ongoing global market access trends - Upcoming webinars and events, including interviews with healthcare professionals and other experts - Policy updates and insights relevant to local healthcare markets - Explanations and discussions of health economics and evidence generation techniques - Showcase of our latest value communication and digital tools - Interviews with Petauri colleagues, insights into our culture, and opportunities to join our team